Status:
COMPLETED
A Crossover Study to Evaluate the Efficacy of Simvastatin in Elevating HDL-C Levels in Patients With Type 2 Diabetes (0733-216)(COMPLETED)
Lead Sponsor:
Organon and Co
Conditions:
HDL Cholesterol
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to see how well simvastatin raises HDL levels in patients with Type 2 Diabetes.
Eligibility Criteria
Inclusion
- Patient has stable Type 2 diabetes mellitus at Visit 1.
- Patient meets screening criteria based on Visit 1 lab tests
Exclusion
- Patient is pregnant, breastfeeding, or at risk of becoming pregnant
- Patient has heart disease, uncontrolled high blood pressure, or other significant disease
- Patient is taking prohibited medication(s) and is unable to stop taking them for the duration of the study
Key Trial Info
Start Date :
July 26 2001
Trial Type :
INTERVENTIONAL
End Date :
October 4 2002
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00389896
Start Date
July 26 2001
End Date
October 4 2002
Last Update
August 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.